Published on Monday April 29, 2013
Smooth Drug Development starts development of a new vaccine
Smooth Drug Development starts development of a new vaccine against pneumonia.
Development of registration strategy includes evaluation of the information on the drug and creation of the pre-clinical and clinical research program.
Preparation of the registration strategy involves pre-clinical specialists, biomedical statisticians, medical writers, drug registration and regulatory support specialists. If necessary, we make requests to regulatory bodies for detailed advice.
Smooth Drug Development, a leading CRO in Russia, CIS and Baltic countries, provides a full range of clinical trial services since 2011.